<DOC>
	<DOCNO>NCT00094757</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness investigational drug patient Type 2 Diabetes Mellitus .</brief_summary>
	<brief_title>An Investigational Drug Study Patients With Type 2 Diabetes Mellitus ( MK0431-023 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients least 18 year age old 75 specific type diabetes call Type 2 Diabetes Mellitus Younger 18 year age older 75 Any condition , opinion investigator , may patient 's best interest participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>